• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

29.46 +0.74 (+2.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,141,118
Open 28.80
Bid (Size) 26.70 (100)
Ask (Size) 30.90 (100)
Prev. Close 28.72
Today's Range 28.51 - 30.23
52wk Range 22.24 - 46.00
Shares Outstanding 58,951,469
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss ↗
Today 14:05 EDT
Agios Pharmaceuticals (NASDAQ:AGIO) used an investor webcast tied to the 2026 European Hematology Association Congress in Stockholm to highlight new clinical data for mitapivat across thalassemia and... 
Via MarketBeat
News headline image
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
May 22, 2026
From Avanzanite Bioscience B.V. and Agios Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
+8.4%
+8.4%
1 Month
+3.7%
+3.7%
3 Month
+6.8%
+6.8%
6 Month
+7.3%
+7.3%
1 Year
-14.4%
-14.4%

More News

Read More
News headline image
Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances ↗
May 19, 2026
Via MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Q1 2026 Earnings Beat Drives Stock Rally ↗
April 29, 2026
Via Chartmill
Topics Earnings
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Q4 2025 Revenue Beat and Narrower Loss ↗
February 12, 2026
Via Chartmill
News headline image
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) ↗
May 02, 2026
Via The Motley Fool
News headline image
Agios (AGIO) Q1 2026 Earnings Call Transcript ↗
April 30, 2026
Via The Motley Fool
Topics Earnings
News headline image
Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday ↗
April 29, 2026
Via The Motley Fool
News headline image
Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) ↗
April 24, 2026
Via The Motley Fool
News headline image
Agios (AGIO) Q3 2024 Earnings Call Transcript ↗
April 22, 2026
Via The Motley Fool
Topics Earnings
News headline image
Agios (AGIO) Q2 2025 Earnings Call Transcript ↗
April 21, 2026
Via The Motley Fool
Topics Earnings
News headline image
Agios (AGIO) Q3 2025 Earnings Transcript ↗
April 21, 2026
Via The Motley Fool
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
April 20, 2026
Via Chartmill
News headline image
Here's Why Agios Pharmaceuticals Crashed 23% Today ↗
April 20, 2026
Via The Motley Fool
What's going on in today's session ↗
April 20, 2026
Via Chartmill
These stocks are gapping in today's session ↗
April 20, 2026
Via Chartmill
News headline image
Why Is Agios Pharmaceuticals Stock Surging Tuesday Afternoon? ↗
March 31, 2026
Via Benzinga
News headline image
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today ↗
March 31, 2026
Via The Motley Fool
News headline image
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything ↗
March 31, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
February 23, 2026
Via The Motley Fool
News headline image
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
February 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Agios (AGIO) Q4 2025 Earnings Call Transcript ↗
February 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter ↗
December 24, 2025
Via Stocktwits
Topics ETFs Economy Stocks
News headline image
Here's Why Shares in Agios Pharmaceuticals Popped Today ↗
December 24, 2025
Via The Motley Fool
News headline image
Which stocks are gapping on Wednesday? ↗
December 24, 2025
Via Chartmill

Frequently Asked Questions

Is Agios Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Agios Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Agios Pharmaceuticals, Inc. - Common Stock trade on?
Agios Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock is AGIO on the Nasdaq Stock Market
What is the current price of Agios Pharmaceuticals, Inc. - Common Stock?
The current price of Agios Pharmaceuticals, Inc. - Common Stock is 29.46
When was Agios Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Agios Pharmaceuticals, Inc. - Common Stock was at 06/12/26 04:00 PM ET
What is the market capitalization of Agios Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Agios Pharmaceuticals, Inc. - Common Stock is 1.74B
How many shares of Agios Pharmaceuticals, Inc. - Common Stock are outstanding?
Agios Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap